|
Real-time Estimate
Cboe BZX
02:03:53 05/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 127.93 USD | -0.05% |
|
+2.71% | +29.33% |
| 09-01 | Incyte Corporation Enters Agreement with U.S. Centers for Medicare & Medicaid Services | CI |
| 08-29 | US FDA approves Takeda, Protagonist's drug for rare blood cancer | RE |
| Market Cap | 25.95B 22.33B 21.01B 19.19B 35.9B 2,450B 35.99B 248B 96.32B 1,257B 97.43B 95.3B 4,049B | P/E 2026 * |
57.1x | P/E 2027 * | 17.7x |
|---|---|---|---|---|---|
| Enterprise Value | 21.72B 18.69B 17.58B 16.06B 30.04B 2,050B 30.13B 208B 80.62B 1,052B 81.54B 79.77B 3,389B | EV / Sales 2026 * |
3.65x | EV / Sales 2027 * | 3.19x |
| Free-Float |
98.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| INCY | Delayed | |
CBOE
| INCY | Real-time | |
|
Mexican S.E.
| INCY * | End-of-day quote | |
|
Berne S.E.
| ICY | End-of-day quote | |
|
Tradegate
| ICY | Real-time | |
|
Börse Stuttgart
| ICY | Delayed | |
|
Boerse Muenchen
| ICY | Real-time | |
|
Borsa Italiana
| 1INCY | End-of-day quote | |
|
Deutsche Boerse AG
| ICY | Delayed | |
|
Xetra
| ICY | Delayed |
Last Transcript : Incyte Corporation
| 1 day | -0.01% | ||
| 1 week | +2.71% | ||
| Current month | +3.67% | ||
| 1 month | +5.92% | ||
| 3 months | +26.18% | ||
| 6 months | +29.21% | ||
| Current year | +29.33% |
| 1 week | 121.61 |  | 130 |
| 1 month | 115.77 | | 130.8 |
| Current year | 89.25 | | 132.6 |
| 1 year | 81.09 | | 132.6 |
| 3 years | 50.27 | | 132.6 |
| 5 years | 50.27 | | 132.6 |
| 10 years | 50.27 | | 153.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Meury
CEO | Chief Executive Officer | 58 | 26/06/2025 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 57 | 04/05/2026 |
Pablo Cagnoni
PSD | President | 62 | 05/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baker
CHM | Chairman | 59 | 26/06/2025 |
| Director/Board Member | 72 | 20/01/2015 | |
Paul Clancy
BRD | Director/Board Member | 64 | 20/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/8/26 | Tax | EVP, Human Resources | -504 | 0.0002% | ||
| 19/8/26 | Sell | Chairperson | -10,801 | 0.0053% | ||
| 12/8/26 | Sell | Chairperson | -10,803 | 0.0053% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.05% | +2.71% | +49.51% | +101.86% | 25.95B | |
| -1.16% | +4.91% | +46.89% | +1.25% | 84.22B | |
| -0.57% | +0.36% | -15.55% | -35.15% | 60.48B | |
| -1.75% | +5.33% | +498.64% | +32.91% | 59.43B | |
| -2.03% | -9.22% | -7.00% | +28.39% | 50.31B | |
| -4.58% | -2.73% | +2.93% | +157.71% | 48.91B | |
| -1.44% | +1.07% | +57.81% | -17.07% | 33.17B | |
| -0.19% | -4.83% | -4.30% | +191.74% | 22.78B | |
| -1.13% | -2.45% | +65.99% | +110.75% | 16.73B | |
| -1.17% | -2.87% | +43.55% | +151.18% | 14.74B | |
| Average | -1.47% | -0.40% | +73.85% | +72.36% | 41.67B | |
| Weighted average by Cap. | -1.62% | +0.71% | +89.48% | +47.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.94B 5.11B 4.81B 4.39B 8.22B 561B 8.24B 56.85B 22.06B 288B 22.31B 21.83B 927B | 6.27B 5.39B 5.07B 4.63B 8.67B 592B 8.69B 59.94B 23.26B 303B 23.53B 23.01B 978B |
| Net income | 466M 401M 377M 345M 644M 43.98B 646M 4.46B 1.73B 22.57B 1.75B 1.71B 72.7B | 1.5B 1.29B 1.21B 1.11B 2.07B 141B 2.08B 14.31B 5.55B 72.46B 5.62B 5.49B 233B |
| Net Debt | -4.23B -3.64B -3.42B -3.13B -5.85B -399B -5.87B -40.47B -15.7B -205B -15.88B -15.54B -660B | -5.99B -5.16B -4.85B -4.43B -8.29B -566B -8.31B -57.31B -22.24B -290B -22.5B -22.01B -935B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/09/26 | US$127.79 | -0.17% | 231,184 |
| 03/09/26 | US$128.00 | -0.64% | 910,226 |
| 02/09/26 | US$128.83 | +3.06% | 2,324,205 |
| 01/09/26 | US$125.01 | +1.45% | 1,191,993 |
| 31/08/26 | US$123.22 | -0.92% | 1,483,195 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INCY Stock
Select your edition
All financial news and data tailored to specific country editions
